A Study to Evaluate the Use of Durvalumab in Combination With Platinum-based Chemotherapy Followed by Durvalumab With Olaparib as First-line Treatment in Advanced or Recurrent Endometrial Cancer in Spain
Clinical trial NCT06746116 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06746116
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-30
- Primary completion
- 2028-11-30
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.